Obligatory medical device diagnostics.
Medical device diagnostics are used when a pheochromocytoma is confirmed by laboratory diagnosis and are used to determine the location of the pheochromocytoma.
- Computed tomography (CT) of the abdomen (abdominal CT) or magnetic resonance imaging (abdominal MRI) – sensitivity (percentage of diseased patients in whom the disease is detected by use of the procedure, i.e., a positive finding occurs) approximately 95% and specificity probability that actually healthy individuals who do not have the disease in question are also detected as healthy by the procedure) approximately 75%.
- Sonography (ultrasound examination) or endosonography (endoscopic ultrasound (EUS); ultrasound examination performed from the inside, i.e., the ultrasound probe is brought into direct contact with the internal surface (for example, the mucosa of the stomach/intestine) by means of an endoscope (optical instrument)).
- Scintigraphy (imaging nuclear medicine procedure) with 123iodine-MIBG (meta-iodine-benzylguanidine scintigraphy) or the combined DOPA-PET/CT – to exclude/detect extraadrenal pheochromocytomas.
